Page 6 - HME Business, January/February 2022

Editor’s Note
The Chips Have Fallen
The microchip shortage has hit healthcare hard, but Congress is only solving part of the problem.
It’s funny how expressions morph over time. These days, when people say, “let the chips fall where they may,” they tend to imply that a person shouldn’t worry about small details. However, the 19th century idiom, derived from chopping wood, means that when performing an important job or making a big decision, it’s important to focus on the main task at hand (chopping logs) without worrying about the consequences of the job (the chips) that might be unknown. The phrase recognizes that the chips are also important.
That expression couldn’t be more apropos for the history of the U.S. semiconductor and microchip supply, which is now so tight that it’s impacting healthcare and the HME industry. We are now confronted by the fallout of decisions made in the past, and it’s going to require the government to fix them. But how well is the government doing?
The current situation: multiple supply chain issues are causing shortages of the microchips used in many medical devices, such as oxygen concentrators, CPAPs and ventilators. Moreover, the supply chain problems are compounded by the fact that other industries and products ranging from automobiles to consumer electronics use the same chips. The supply and demand are completely out of balance.
How bad is the shortage? Researchers AutoForecast Solutions estimated the world lost 11.3 million units of production in 2021 and will likely lose 7 million more units in 2022.
So, why is there a shortage? The short answer is the pandemic’s overall supply chain impact.
However, the underlying reason we find ourselves in this position is due to manufacturing decisions made by U.S. semiconductor and microchip companies three decades ago. Starting in the early 1990s, the U.S. semiconductor industry began focusing on innovation while offshoring its production capacity. That trend only increased at the beginning of the 21st century. Nowadays, the is scant domestic production. According to Brookings, as of 2020, the United States only accounted for 12 percent of global semiconductor manufacturing.
So, as soon as the pandemic started choking off the flow of goods into U.S. ports, the flow of component electronics such as microchips plummeted. Add to that the fact that the United States was in a trade war with China and implemented policies that impacted Chinese chip manufacturers, as well as fires at key plants and weather-related production problems, and the supply of microchips suffered even more.
Fortunately, because the microchip shortage affects so many U.S. industries, Congress is working to address the situation through increased domestic semiconductor and microchip production. The House is currently working to pass the America COMPETES Act of 2022, the lower chamber’s sister bill to the Senate’s U.S. Innovation and Competition Act (USICA), which the upper body passed in June. Both bills would provide appropriations language to fund $52 billion for domestic semiconductor R&D and production.
But the bills don’t address the current situation. We won’t see the output from any increase in domestic production of microchips resulting from the bills’ funding for some time. In the meantime, we still have a chip shortage impacting the United States, and in particular, our healthcare infrastructure while we continue to grapple with the Covid-19 pandemic.
The solution to this very-present problem is something most people in healthcare will recognize: triage. Either through regulation or legislation, the federal government must work to temporarily implement some kind of hierarchy for distributing chips so that manufacturers of healthcare equipment either get priority or a larger share of chips coming into U.S. ports. The country’s healthcare and pandemic response depend on it.
David Kopf
Publisher & Executive Editor HME Business
Volume 29 Number 1 January/February 2022
hme-business.com EXECUTIVE EDITOR & PUBLISHER
EDITORIAL STAFF ART STAFF
David Kopf
(949) 265-1561
Laurie Layman
Teresa Antonio
Marlin Mowatt
Rick Neigher
(818) 597-9029
Randy Easton
(678) 591-2822
SENIOR ART DIRECTOR
PRODUCTION STAFF
PRODUCTION COORDINATOR
ONLINE STAFF
DIR. OF ONLINE PRODUCT DEVELOPMENT
SALES STAFF
GROUP SALES MANAGER INTEGRATED MEDIA CONSULTANT
EDITORIAL ADVISORY BOARD
Steve Ackerman
President Spectrum Medical
Jeffrey S. Baird, Esq.
Chairman of the Health Care Group of Brown & Fortunato, P.C.
Cara Bachenheimer
Lobbyist/Government Affairs for Brown & Fortunato, P.C.
Rob Baumhover
Director of Retail Services for VGM Retail Services
Ty Bello, RCC
President and Founder Team@Work
Sandra Canally
President
The Compliance Team Inc.
John Letizia
President of Laurel Medical Supplies Inc.
Joe Lewarski
Vice President of Global Respiratory and Sleep Drive Devilbiss
Josh Marx
Managing Director, Sleep & VP of Business Development, Medical Service Company
Trish Nettleship
Vice President of Marketing, Brightree LLC
Faisal “RJ” Poonawala
President
Spring Branch Medical Supply
Ron Resnick
President
Blue Chip Medical Products Inc.
Tom Ryan
President and CEO AAHomecare
Rose Schafhauser
Executive Director
Midwest Association for Medical Equipment Suppliers
Gary Sheehan, MBA
President and CEO Cape Medical Supply
Wayne van Halem
President and Founder The van Halem Group LLC
INFRASTRUCTURE SOLUTIONS GROUP
PRESIDENT & GROUP PUBLISHER GROUP CIRCULATION DIRECTOR GROUP MARKETING DIRECTOR
CHIEF EXECUTIVE OFFICER CHIEF FINANCIAL OFFICER CHIEF TECHNOLOGY OFFICER
EXECUTIVE VICE PRESIDENT
REACHING THE STAFF
Kevin O’Grady Irene Fincher Susan May
Rajeev Kapur Sanjay Tanwani Erik A. Lindgren
Michael J. Valenti
Editors can be reached via e-mail, fax, telephone, or mail. A list of editors and contact information is at www.hme-business.com.
Email: To e-mail any member of the staff please use the follow- ing form: FirstinitialLastname@1105media.com.
Dallas Office: (weekdays, 8:30 a.m. – 5:30 p.m. CT) Telephone: 972-687-6700; Fax: 972-687-6799 14901 Quorum Drive, Suite 425, Dallas, TX 75254
Corporate Office: (weekdays, 8:30 a.m. – 5:30 p.m. PT) Telephone: 818-814-5200; Fax: 818-734-1522
6300 Canoga Avenue, Suite 1150, Woodland Hills, CA 91367
6 HMEBusiness | January/February 2022 | hme-business.com
Management Solutions | Technology | Products